Literature DB >> 11208329

Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier.

C Pakulski1, L Drobnik, B Millo.   

Abstract

INTRODUCTION: The aim of the study was to find out, if there was a difference in function of the blood/cerebrospinal fluid barrier (BCSFB) in females and males, and if those differences intensify with age.
MATERIAL AND METHODS: 120 patients of both sexes who underwent subarachnoideal anesthesia were divided into 6 groups, 20 patients each, considering sex and age criteria. Samples of venous blood (5 ml) and cerebrospinal fluid (1 ml) were collected from every patient simultaneously; then albumin permeability indexes (Qalb) were counted. The achieved results were compared using the t-Student test at the significance level of P < or = 0.05.
RESULTS: The mean value of Qalb in patients aged 20-50 was significantly lower than in the group of patients aged 51-70, as well as in the group of patients over 71. The difference between mean Qalb values in patients aged 51-70 and those aged over 71 was also statistically significant. No statistically significant difference between mean Qalb values in females and in males in the corresponding age groups was found. In every age group the value of albumin permeability index was lower in females.
CONCLUSIONS: 1) The permeability of BCSFB increases with age. 2) There was no statistically significant difference between the values of albumin permeability index in females and males in the corresponding age groups. The function of BCSFB in the corresponding age groups of males and females was the same.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11208329

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  19 in total

1.  Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.

Authors:  Tzu-Fang Lou; Deepa Sethuraman; Patrick Dospoy; Pallevi Srivastva; Hyun Seok Kim; Joongsoo Kim; Xiaotu Ma; Pei-Hsuan Chen; Kenneth E Huffman; Robin E Frink; Jill E Larsen; Cheryl Lewis; Sang-Won Um; Duk-Hwan Kim; Jung-Mo Ahn; Ralph J DeBerardinis; Michael A White; John D Minna; Hyuntae Yoo
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-28

Review 2.  [Urinary incontinence and urodynamics].

Authors:  K-P Jünemann; H Palmtag; C Hampel; H Heidler; G Naumann; H Kölbl; C van der Horst; D Schultz-Lampel
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 3.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

4.  Anticholinergics and central nervous system effects: are we confused?

Authors:  David R Staskin; Edward Zoltan
Journal:  Rev Urol       Date:  2007

Review 5.  Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease.

Authors:  Farida Sohrabji
Journal:  Gene Expr       Date:  2007

6.  [Drug therapy of female urinary incontinence].

Authors:  C Hampel; R Gillitzer; S Pahernik; S W Melchior; J W Thüroff
Journal:  Urologe A       Date:  2005-03       Impact factor: 0.639

7.  Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.

Authors:  Elizabeth J Geller; Andrea K Crane; Ellen C Wells; Barbara L Robinson; Mary L Jannelli; Christine M Khandelwal; Annamarie Connolly; Brent A Parnell; Catherine A Matthews; Julie B Dumond; Jan Busby-Whitehead
Journal:  Clin Drug Investig       Date:  2012-10-01       Impact factor: 2.859

8.  Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.

Authors:  Jon Lampa; Marie Westman; Diana Kadetoff; Anna Nordenstedt Agréus; Erwan Le Maître; Caroline Gillis-Haegerstrand; Magnus Andersson; Mohsen Khademi; Maripat Corr; Christina A Christianson; Ada Delaney; Tony L Yaksh; Eva Kosek; Camilla I Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 9.  Sex Differences in Human and Animal Toxicology.

Authors:  Michael Gochfeld
Journal:  Toxicol Pathol       Date:  2016-11-28       Impact factor: 1.902

Review 10.  Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin.

Authors:  G G Kay; U Ebinger
Journal:  Int J Clin Pract       Date:  2008-08-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.